Umeå School of Business, Economics and Statistics, Statistics, Västerbotten, Sweden.
Department of Clinical Microbiology, Umeå University, Umeå, Sweden.
Front Cell Infect Microbiol. 2023 Jul 3;13:1192038. doi: 10.3389/fcimb.2023.1192038. eCollection 2023.
Interpretation of serological findings in suspected Lyme borreliosis (LB) is challenging and IgM reactivities may have low predictive value. Therefore, if used indiscriminately, there is a risk for incorrect diagnosis of LB. To evaluate the usefulness of IgM titer determination, we performed a study of the prevalence of -specific antibodies in serological samples from patients with suspected LB analyzed during the period 2010 - 2021 at the University Hospital of Umeå in Sweden. In total, 19,335 samples had been analyzed for the presence of IgG and IgM antibodies. Overall, there were higher percentages of IgM positive or borderline titers, 1,847 (9.6%) and 905 (4.7%), respectively, than IgG positive or borderline titers, 959 (5.0%) and 406 (2.1%), respectively. Peak number of samples were recorded 2012 - 2013, exceeding 1,800, whereas there were around 1,200 during 2020 - 2021. The peak number of positive IgG and/or positive IgM samples were observed during the period 2015 - 2017 with close to, or above 400, and concomitantly, the proportion of IgG positive samples increased markedly. For IgG positive samples, the increase followed a positive linear time trend (< 0.001). Peak monthly numbers were observed during August, September, and October. This seasonal increase was significant for the IgG positive group (< 0.05), but not for the IgM positive/IgG negative group. Repeated samples were obtained from 3,188 individuals and of the initial samples 2,817 were (88%) IgG negative and 2,315 (72%) were IgM negative and of these, 130 (4%) showed IgG seroconversion and 300 (9%) IgM seroconversion. Collectively, the data demonstrate that IgG and/or IgM positive samples represented a minority of all samples, even when repeated sampling had occurred, and IgM positive samples were much more common than IgG positive samples. Thus, the accuracy of the clinical suspicion was low and this will lead to a low predictive value of the analysis, in particular of IgM. These findings question the use of IgM titer determination as a routine analysis.
对疑似莱姆病(LB)的血清学结果进行解释具有挑战性,IgM 反应可能具有较低的预测价值。因此,如果不加区分地使用,可能会导致 LB 的误诊。为了评估 IgM 滴度测定的有用性,我们对 2010 年至 2021 年期间在瑞典于默奥大学医院分析的疑似 LB 患者的血清学样本中的特异性抗体进行了研究。总共分析了 19335 个样本,以确定 IgG 和 IgM 抗体的存在。总体而言,IgM 阳性或边界滴度(分别为 1847 例[9.6%]和 905 例[4.7%])的百分比高于 IgG 阳性或边界滴度(分别为 959 例[5.0%]和 406 例[2.1%])。记录到的样本数量峰值出现在 2012-2013 年,超过 1800 例,而 2020-2021 年期间约为 1200 例。阳性 IgG 和/或阳性 IgM 样本的数量峰值出现在 2015-2017 年期间,接近或超过 400 例,同时,IgG 阳性样本的比例显著增加。对于 IgG 阳性样本,增加趋势呈正线性(<0.001)。8 月、9 月和 10 月观察到月度样本数量峰值。这种季节性增加在 IgG 阳性组中具有统计学意义(<0.05),但在 IgM 阳性/IgG 阴性组中则没有。从 3188 个人中获得了重复样本,初始样本中有 2817 个(88%)IgG 阴性,2315 个(72%)IgM 阴性,其中 130 个(4%)显示 IgG 血清转化,300 个(9%)显示 IgM 血清转化。总体而言,即使在进行了重复采样的情况下,IgG 和/或 IgM 阳性样本也仅代表所有样本的一小部分,并且 IgM 阳性样本比 IgG 阳性样本更为常见。因此,临床怀疑的准确性较低,这将导致分析的预测价值较低,特别是 IgM 的分析。这些发现质疑了将 IgM 滴度测定作为常规分析的使用。